Abstract
A 12-year-old girl with Sly disease (mucopoly- saccharidosis VII; β-glucuronidase deficiency), who is homozygous for the A619V mutation, had a successful allogeneic BMT, donored by an HLA-identical unrelated female to replace the deficient enzyme. Within 5 months after BMT, the enzyme activity of the recipient’s lymphocytes increased to normal range. No signs of acute or chronic GVHD were observed. For the successive 31 months post-BMT, β-glucuronidase activity in her lymphocytes was maintained at almost normal levels and excretion of glycosaminoglycans in the urine was greatly diminished. Ultrastructural findings demonstrated no abnormal vacuoles and inclusion bodies in the cytoplasm of her rectal mucosal cells. Coincident with the restoration of the enzyme activity, clinical improvement was dramatic. Especially notable were improvements in motor function. The patient was able to walk alone for a long time without aid, and she even became able to ride a bicycle and take a bath. In addition, recurrent infections of the upper respiratory tract and the middle ears decreased in frequency and severity, and dyspnea on exertion, severe snoring and vertigo have substantially improved. Thus, allogeneic BMT in this patient produced a better quality of life and provided a more promising outlook.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Yamada, Y., Kato, K., Sukegawa, K. et al. Treatment of MPS VII (Sly disease) by allogeneic BMT in a female with homozygous A619V mutation. Bone Marrow Transplant 21, 629–634 (1998). https://doi.org/10.1038/sj.bmt.1701141
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1701141
Keywords
This article is cited by
-
Failures of Endochondral Ossification in the Mucopolysaccharidoses
Current Osteoporosis Reports (2020)
-
Pathway to diagnosis and burden of illness in mucopolysaccharidosis type VII – a European caregiver survey
Orphanet Journal of Rare Diseases (2019)
-
Recent trends in mucopolysaccharidosis research
Journal of Human Genetics (2019)
-
Vestronidase Alfa: A Review in Mucopolysaccharidosis VII
BioDrugs (2019)
-
Therapeutic Options for Mucopolysaccharidoses: Current and Emerging Treatments
Drugs (2019)